Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Blend Labs
BLND
$431M
| $3.26M | ﹤0.01% |
3,446,136
+3,338,357
| +3,097% | +$2.96M |
|
3002
PUT
Bank OZK
OZK
$5.6B
| $3.25M | ﹤0.01% |
+80,900
| New | +$2.9M |
|
3003
PUT
Inspire Medical Systems
INSP
$1.45B
| $3.25M | ﹤0.01% |
+10,000
| New | +$2.86M |
|
3004
iShares MSCI China ETF
MCHI
$6.32B
| $3.25M | ﹤0.01% |
72,544
-175,943
| -71% | -$8.23M |
|
|
NVO
3005
PUT
Novo Nordisk
NVO
$208B
| $3.24M | ﹤0.01% |
40,000
+25,400
| +174% | +$2.07M |
|
3006
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
| $3.24M | ﹤0.01% |
77,301
-51,095
| -40% | -$2.11M |
|
3007
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $3.23M | ﹤0.01% |
110,001
+51,000
| +86% | +$1.49M |
|
|
SEM
3008
DELISTED
Select Medical
SEM
| $3.23M | ﹤0.01% |
188,289
+76,951
| +69% | +$1.19M |
|
3009
PUT
Martin Marietta Materials
MLM
$31.5B
| $3.23M | ﹤0.01% |
7,000
+5,000
| +250% | +$1.97M |
|
|
DJTWW
3010
CALL
Trump Media & Technology Group Warrants
DJTWW
$787M
| $3.23M | ﹤0.01% |
1,242,766
| – | – |
|
3011
Amerant Bancorp
AMTB
$1.16B
| $3.23M | ﹤0.01% |
187,854
-62,678
| -25% | -$1.17M |
|
3012
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
| $3.22M | ﹤0.01% |
128,945
-162,132
| -56% | -$4.25M |
|
3013
Newell Brands
NWL
$2.38B
| $3.22M | ﹤0.01% |
370,246
-1,952,422
| -84% | -$19.4M |
|
3014
PUT
GE HealthCare
GEHC
$30.7B
| $3.22M | ﹤0.01% |
+39,600
| New | +$3.16M |
|
3015
Expensify
EXFY
$176M
| $3.21M | ﹤0.01% |
402,880
-543,899
| -57% | -$3.99M |
|
|
CHEA
3016
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
| $3.21M | ﹤0.01% |
300,000
| – | – |
|
3017
CALL
Glaukos
GKOS
$9.83B
| $3.2M | ﹤0.01% |
+45,000
| New | +$2.58M |
|
3018
Scholastic
SCHL
$767M
| $3.2M | ﹤0.01% |
82,352
+69,280
| +530% | +$2.69M |
|
3019
GrafTech
EAF
$175M
| $3.2M | ﹤0.01% |
63,406
-13,473
| -18% | -$627K |
|
|
CITE
3020
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $3.19M | ﹤0.01% |
300,000
| – | – |
|
3021
Amneal Pharmaceuticals
AMRX
$5.85B
| $3.19M | ﹤0.01% |
1,028,641
-2,065,044
| -67% | -$4.4M |
|
3022
Westamerica Bancorp
WABC
$1.38B
| $3.19M | ﹤0.01% |
83,230
-227,894
| -73% | -$9.11M |
|
3023
PUT
Monolithic Power Systems
MPWR
$70.1B
| $3.19M | ﹤0.01% |
+5,900
| New | +$2.8M |
|
|
MORF
3024
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $3.18M | ﹤0.01% |
55,552
+22,419
| +68% | +$1.17M |
|
|
TRTX
3025
TPG RE Finance Trust
TRTX
$612M
| $3.18M | ﹤0.01% |
429,767
+292,891
| +214% | +$1.98M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.